• No results found

5-ASA - colorectal cancer - cell death : an intriguing threesome Koelink, P.J.

N/A
N/A
Protected

Academic year: 2021

Share "5-ASA - colorectal cancer - cell death : an intriguing threesome Koelink, P.J."

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

5-ASA - colorectal cancer - cell death : an intriguing threesome

Koelink, P.J.

Citation

Koelink, P. J. (2010, January 14). 5-ASA - colorectal cancer - cell death : an intriguing threesome. Retrieved from https://hdl.handle.net/1887/14563

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/14563

Note: To cite this publication please use the final published version (if applicable).

(2)

175

List of publications

Koelink PJ, Mieremet-Ooms MA, Corver WE, Wolanin K, Hommes DW, Lamers CB, Verspaget HW. 5-aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cell death modes. Inflammatory Bowel Diseases 2009 Sep 22 [epub ahead of print].

Koelink PJ, Sier CF, Hommes DW, Lamers CB, Verspaget HW. Clinical significance of stromal apoptosis in colorectal cancer. Br J of Cancer 2009;101(5):765-73.

Koelink PJ, Hawinkels LJ, Wiercinska E, Sier CF, Dijke PT, Lamers CB, Hommes DW, Verspaget HW. 5-Aminosalicylic acid inhibits TGF-beta1 signalling in colorectal cancer cells. Cancer Letters 2009 Jun 19 [epub ahead of print].

Koelink PJ, Robanus-Maandag EC, Devilee P, Hommes DW, Lamers CB, Verspaget HW. 5- Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional APC mouse model. Carcinogenesis 2009;20(7): 1217-24.

Koelink PJ, Lamers CB, Hommes DW, Verspaget HW. Circulatinf cell death products predict clinical outcome of colorectal cancer patients. BMC Cancer 2009;9:88.

Vischer HF, Granneman JC, Koelink PJ, Marques RB, Bogerd J. Identification of a luteinizing hormone selective determinant in the exodomain of a follicle-stimulating hormone receptor. Gen Comp Endocrinol. 2008;156(3):490-8.

Koelink PJ, Verspaget HW. 5-ASA and colorectal cell-cycle progression. Gastroenterology 132; (4):1635-6.

Chapters in books:

Aletta D. Kraneveld, Saskia Braber, Saskia Overbeek, Petra de Kruijf, Pim Koelink, Martine Smit. ‘Role chemokine receptors in inflammation’ in ‘Chemokine receptors as Drug Targets’

Wiley Press2009.

(3)

176

Referenties

GERELATEERDE DOCUMENTEN

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. 5-aminosalicylate use and colorectal cancer risk in

In the groups with high caspase- 3 activity the disease-free survival was found to be the best for patients with a high tumour caspase-3 activity and low M30 antigen level

For instance, docetaxel treatment increased levels of M30 antigen in the serum of breast cancer patients, indicating apoptotic death of tumour cells, while

The significant loss of total CK18 antigen levels in the post 5-ASA carcinoma biopsies indicates that 5-ASA caused the elimination of epithelial (cancer) cells within

5-ASA inhibited TGF- β1 signalling in HCT116 cells and colonic fibroblasts, as judged by a TGF-β- specific reporter gene assay, plasminogen activator inhibitor-1 mRNA and

In the first experiment the effect of 5-ASA was tested on DSS-induced colitis-associated neoplasia development in FabplCre;Apc 15lox/+ mice at 5 weeks of age,

In addition, 5-ASA treatment was found to increase the survival of mice subjected to lethal radiation doses, whereas the survival of irradiated animals with

The simultaneous decrease in CK18 levels in post-5-ASA biopsies, implicating a loss of epithelial cell content due to 5-ASA treatment, could well be the result of a